We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Celestial Labs is a drone display company that combines advanced technology with organic performance. The company's proprietary 'Skytheatre' display is a dynamic, safe and green alternative to carbon-intensive fireworks and represents a new frontier for the live event industry. Composed of a creative collective of award-winning filmmakers, musicians, developers, entrepreneurs, and storytellers, the company is constantly pushing the boundaries of drone display innovation, where technology meets imagination. The Human Support division of Celestial is a not-for-profit initiative that aims to lift the spirits of those who witness Celestial's displays whilst imparting crucial information. The company aims to enlist the support and guidance of city leadership partners, industrial conglomerates, and seek grant funding.
days to go: Stretch investment: Withheld
Stroli – the shopping trolley reimagined for modern needs. The shopping trolley, often associated with a particular image, is an untapped category ready for innovation. The market is flooded with generic, budget-friendly options that lack charm, with the exception of Rolser, which is pricier and claims the green niche. Stroli steps in as the go-to brand, offering a unique approach, positioning, voice, and eco-friendly credentials. Say goodbye to sore hands and plastic bags – Stroli makes shopping a pleasure with its high-quality, stylish trolley bags designed to enhance your convenience and style
days to go: Extended investment: Withheld
Bioepic is an app which enables users to easily and non-invasively measure their health status in just 30 seconds using just a smartphone. The app calculates pulse wave velocity, body temperature, blood pressure, heart rate variability chaos, vascular stiffness and the effectiveness of inhalers. 
days to go: Expired investment: £12,500
Symmetrical Power has developed an innovative solution that addresses the issue of energy wastage. After identifying the inefficiency of the 3 Phase Electrical Distribution Boards, Symmetrical Power is creating the ‘Intelligent Distribution Board’ (ID Board). It aims to prevent the challenge of peak demand whilst saving on energy bills. The working model of the product also received positive feedback from electrical specialists. Additionally, Symmetrical Power was also a Shell Springboard regional finalist (2018) for its new low-carbon ideas. With the proceeds, the company will complete design & begin distribution in Europe and to position itself as the go-to Distribution Board provider.

Pitch Rated

81%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £233,600
The GP Service is a web and application-based platform that provides private consultations for patients across the UK. The aim is to provide a safe and easy journey for individuals who are looking for private medical treatment at their convenience and at an affordable cost. They have established a connection with over 1600 pharmacies across the UK. They have an excellent 5-star trust pilot rating and also are 1st Private Online Provider which has access to NHS Medical Records. With the proceeds, the company will scale the enterprise offering, increase brand awareness and also launch additional revenue opportunities.

Pitch Rated

77%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £907,540
Perkier is the UK’s fastest growing healthy snack bar brand. It asserts that its bars are 100% plant based, contain 60% less sugar, and are free from gluten and palm oil. Perkier aspires to dominate the global snack bar market that is worth $22 billion. The company claims that its products are distributed in every Sainsbury’s supermarket, in over 450 Morrisons stores and over 400 ASDA stores. It further points out that it is listed in major foodservice companies including Compass, Brakes and Bidfood. The company has over 55,000 followers across social media, and a brand ambassador program including team GB Olympians reaching 1.6 million people. Perkier states it will use the investment to expand its team, increase digital marketing, and invest in innovation.  
days to go: Expired investment: £811,695
Lemonade Dolls (LD) is the UK's first subscription underwear brand that aims to make hassle-free and comfortable underwear for young women. The company's revenue has grown 550% since January 2020. The Lemonade Dolls brand is sold in Topshop, New Look, and ASOS Marketplace. LD has 2,600 subscribers, 15,000 Dolls on its database, and over 70,000 followers across LD and Lemon's on Instagram. It also aims to bring audiences different brands like Candy Kittens, Frank Body, Dr Paw Paw, Mooncup, and Oh K!. The company has been praised by fashion magazine Grazia as having 'Broken the mould'. The company will use the investment to develop the technology behind its subscription platform, grow its product offering, strengthen its virtual presence, and drive brand awareness.

Pitch Rated

79%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £258,328
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph